Serveur d'exploration sur l'opéra

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).

Identifieur interne : 000078 ( PubMed/Checkpoint ); précédent : 000077; suivant : 000079

Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).

Auteurs : Aki J. K R J M Ki [Finlande] ; Olli-Pekka P Tsi [Finlande] ; Markku Savolainen [Finlande] ; Y Antero Kes Niemi [Finlande] ; Heikki Huikuri [Finlande] ; Olavi Ukkola [Finlande]

Source :

RBID : pubmed:26571029

Abstract

Non-alcoholic fatty liver disease (NAFLD) and atrial fibrillation (AF) are widespread diseases and have multiple common risk factors and comorbidities. No studies of association between ultrasonography-diagnosed NAFLD and AF exist in other than diabetic population. The goal of this prospective study was to study the value of NAFLD as a predictor of atrial fibrillation. This study had 958 subjects from the OPERA (Oulu Project Elucidating Risk of Atherosclerosis) cohort, and the mean follow-up time was 16.3 years. NAFLD was diagnosed if the subject had fatty liver in ultrasonography and no excess alcohol intake. AF was followed in the National Registers. In this study 249 subjects (26.0%) had NAFLD and 37 (14.9%) of these had AF whereas only 56 (7.9%) of those without NAFLD experienced AF during the follow-up time (p = 0.001). In the multiple Cox regression analysis including potential confounders (age, sex, study group, diabetes, body mass index (BMI), waist circumference, alcohol consumption, smoking, serum alanine aminotransferase concentration (ALT), systolic blood pressure, quick index, left ventricular mass index, left atrial diameter, coronary artery disease (CAD), atrial natriuretic peptide (ANP) and high sensitive C-reactive protein (hs-CRP)), NAFLD remained as an independent predictor of AF (Adjusted OR, 1.88 (95% Confidence interval (CI) 1.03-3.45)). In conclusion, our data shows that NAFLD is independently associated with the risk of AF.

DOI: 10.1371/journal.pone.0142937
PubMed: 26571029


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:26571029

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).</title>
<author>
<name sortKey="K R J M Ki, Aki J" sort="K R J M Ki, Aki J" uniqKey="K R J M Ki A" first="Aki J" last="K R J M Ki">Aki J. K R J M Ki</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu</wicri:regionArea>
<wicri:noRegion>Oulu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="P Tsi, Olli Pekka" sort="P Tsi, Olli Pekka" uniqKey="P Tsi O" first="Olli-Pekka" last="P Tsi">Olli-Pekka P Tsi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu</wicri:regionArea>
<wicri:noRegion>Oulu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Savolainen, Markku" sort="Savolainen, Markku" uniqKey="Savolainen M" first="Markku" last="Savolainen">Markku Savolainen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu</wicri:regionArea>
<wicri:noRegion>Oulu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kes Niemi, Y Antero" sort="Kes Niemi, Y Antero" uniqKey="Kes Niemi Y" first="Y Antero" last="Kes Niemi">Y Antero Kes Niemi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu</wicri:regionArea>
<wicri:noRegion>Oulu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Huikuri, Heikki" sort="Huikuri, Heikki" uniqKey="Huikuri H" first="Heikki" last="Huikuri">Heikki Huikuri</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu</wicri:regionArea>
<wicri:noRegion>Oulu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ukkola, Olavi" sort="Ukkola, Olavi" uniqKey="Ukkola O" first="Olavi" last="Ukkola">Olavi Ukkola</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu</wicri:regionArea>
<wicri:noRegion>Oulu</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="doi">10.1371/journal.pone.0142937</idno>
<idno type="RBID">pubmed:26571029</idno>
<idno type="pmid">26571029</idno>
<idno type="wicri:Area/PubMed/Corpus">000035</idno>
<idno type="wicri:Area/PubMed/Curation">000035</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000078</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).</title>
<author>
<name sortKey="K R J M Ki, Aki J" sort="K R J M Ki, Aki J" uniqKey="K R J M Ki A" first="Aki J" last="K R J M Ki">Aki J. K R J M Ki</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu</wicri:regionArea>
<wicri:noRegion>Oulu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="P Tsi, Olli Pekka" sort="P Tsi, Olli Pekka" uniqKey="P Tsi O" first="Olli-Pekka" last="P Tsi">Olli-Pekka P Tsi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu</wicri:regionArea>
<wicri:noRegion>Oulu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Savolainen, Markku" sort="Savolainen, Markku" uniqKey="Savolainen M" first="Markku" last="Savolainen">Markku Savolainen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu</wicri:regionArea>
<wicri:noRegion>Oulu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kes Niemi, Y Antero" sort="Kes Niemi, Y Antero" uniqKey="Kes Niemi Y" first="Y Antero" last="Kes Niemi">Y Antero Kes Niemi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu</wicri:regionArea>
<wicri:noRegion>Oulu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Huikuri, Heikki" sort="Huikuri, Heikki" uniqKey="Huikuri H" first="Heikki" last="Huikuri">Heikki Huikuri</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu</wicri:regionArea>
<wicri:noRegion>Oulu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ukkola, Olavi" sort="Ukkola, Olavi" uniqKey="Ukkola O" first="Olavi" last="Ukkola">Olavi Ukkola</name>
<affiliation wicri:level="1">
<nlm:affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu</wicri:regionArea>
<wicri:noRegion>Oulu</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">PloS one</title>
<idno type="e-ISSN">1932-6203</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Non-alcoholic fatty liver disease (NAFLD) and atrial fibrillation (AF) are widespread diseases and have multiple common risk factors and comorbidities. No studies of association between ultrasonography-diagnosed NAFLD and AF exist in other than diabetic population. The goal of this prospective study was to study the value of NAFLD as a predictor of atrial fibrillation. This study had 958 subjects from the OPERA (Oulu Project Elucidating Risk of Atherosclerosis) cohort, and the mean follow-up time was 16.3 years. NAFLD was diagnosed if the subject had fatty liver in ultrasonography and no excess alcohol intake. AF was followed in the National Registers. In this study 249 subjects (26.0%) had NAFLD and 37 (14.9%) of these had AF whereas only 56 (7.9%) of those without NAFLD experienced AF during the follow-up time (p = 0.001). In the multiple Cox regression analysis including potential confounders (age, sex, study group, diabetes, body mass index (BMI), waist circumference, alcohol consumption, smoking, serum alanine aminotransferase concentration (ALT), systolic blood pressure, quick index, left ventricular mass index, left atrial diameter, coronary artery disease (CAD), atrial natriuretic peptide (ANP) and high sensitive C-reactive protein (hs-CRP)), NAFLD remained as an independent predictor of AF (Adjusted OR, 1.88 (95% Confidence interval (CI) 1.03-3.45)). In conclusion, our data shows that NAFLD is independently associated with the risk of AF.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="In-Process">
<PMID Version="1">26571029</PMID>
<DateCreated>
<Year>2015</Year>
<Month>11</Month>
<Day>17</Day>
</DateCreated>
<DateRevised>
<Year>2015</Year>
<Month>11</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>10</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).</ArticleTitle>
<Pagination>
<MedlinePgn>e0142937</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0142937</ELocationID>
<Abstract>
<AbstractText>Non-alcoholic fatty liver disease (NAFLD) and atrial fibrillation (AF) are widespread diseases and have multiple common risk factors and comorbidities. No studies of association between ultrasonography-diagnosed NAFLD and AF exist in other than diabetic population. The goal of this prospective study was to study the value of NAFLD as a predictor of atrial fibrillation. This study had 958 subjects from the OPERA (Oulu Project Elucidating Risk of Atherosclerosis) cohort, and the mean follow-up time was 16.3 years. NAFLD was diagnosed if the subject had fatty liver in ultrasonography and no excess alcohol intake. AF was followed in the National Registers. In this study 249 subjects (26.0%) had NAFLD and 37 (14.9%) of these had AF whereas only 56 (7.9%) of those without NAFLD experienced AF during the follow-up time (p = 0.001). In the multiple Cox regression analysis including potential confounders (age, sex, study group, diabetes, body mass index (BMI), waist circumference, alcohol consumption, smoking, serum alanine aminotransferase concentration (ALT), systolic blood pressure, quick index, left ventricular mass index, left atrial diameter, coronary artery disease (CAD), atrial natriuretic peptide (ANP) and high sensitive C-reactive protein (hs-CRP)), NAFLD remained as an independent predictor of AF (Adjusted OR, 1.88 (95% Confidence interval (CI) 1.03-3.45)). In conclusion, our data shows that NAFLD is independently associated with the risk of AF.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Käräjämäki</LastName>
<ForeName>Aki J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pätsi</LastName>
<ForeName>Olli-Pekka</ForeName>
<Initials>OP</Initials>
<AffiliationInfo>
<Affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Savolainen</LastName>
<ForeName>Markku</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kesäniemi</LastName>
<ForeName>Y Antero</ForeName>
<Initials>YA</Initials>
<AffiliationInfo>
<Affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huikuri</LastName>
<ForeName>Heikki</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ukkola</LastName>
<ForeName>Olavi</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>11</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2006 Jul 11;114(2):119-25</RefSource>
<PMID Version="1">16818816</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2015;10(8):e0135329</RefSource>
<PMID Version="1">26252899</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2008 Jan;134(1):85-94</RefSource>
<PMID Version="1">18005961</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Heart J. 2008 May;29(9):1181-9</RefSource>
<PMID Version="1">18397874</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Obesity (Silver Spring). 2008 Jun;16(6):1394-9</RefSource>
<PMID Version="1">18369343</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>World J Gastroenterol. 2008 Jun 14;14(22):3476-83</RefSource>
<PMID Version="1">18567074</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Interv Card Electrophysiol. 2008 Aug;22(2):111-8</RefSource>
<PMID Version="1">18264747</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am Heart J. 2009 Jul;158(1):111-7</RefSource>
<PMID Version="1">19540400</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes Care. 2009 Oct;32(10):1851-6</RefSource>
<PMID Version="1">19794003</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Auton Res. 2009 Dec;19(6):319-26</RefSource>
<PMID Version="1">19768633</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cardiol J. 2010;17(5):457-63</RefSource>
<PMID Version="1">20865675</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2010 Sep 30;363(14):1341-50</RefSource>
<PMID Version="1">20879883</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arterioscler Thromb Vasc Biol. 2011 Aug;31(8):1927-32</RefSource>
<PMID Version="1">21546603</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cardiol. 2011 Sep;58(2):116-23</RefSource>
<PMID Version="1">21820280</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Metabolism. 2011 Nov;60(11):1515-20</RefSource>
<PMID Version="1">21565369</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Cardiol. 2012 Jan;27(1):24-8</RefSource>
<PMID Version="1">22139702</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2011 Sep 2;54(3):1082-90</RefSource>
<PMID Version="1">21618575</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:141-7</RefSource>
<PMID Version="1">22262600</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Diabetes Care. 2012 Feb;35(2):389-95</RefSource>
<PMID Version="1">22210573</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2001 Dec 11;104(24):2886-91</RefSource>
<PMID Version="1">11739301</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Coll Cardiol. 2002 Nov 6;40(9):1636-44</RefSource>
<PMID Version="1">12427417</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Duodecim. 2003;119(6):519-29</RefSource>
<PMID Version="1">12708339</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2003 May;37(5):1202-19</RefSource>
<PMID Version="1">12717402</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2003 Dec 16;108(24):3006-10</RefSource>
<PMID Version="1">14623805</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Maturitas. 2004 Mar 15;47(3):201-8</RefSource>
<PMID Version="1">15036490</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2004 Aug 31;110(9):1042-6</RefSource>
<PMID Version="1">15313941</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 1994 Mar 16;271(11):840-4</RefSource>
<PMID Version="1">8114238</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Intern Med. 1999 Feb;245(2):163-74</RefSource>
<PMID Version="1">10081519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2004 Dec;114(12):1752-61</RefSource>
<PMID Version="1">15599400</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2012 Feb 18;379(9816):648-61</RefSource>
<PMID Version="1">22166900</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Heart J. 2012 May;33(10):1190-200</RefSource>
<PMID Version="1">22408036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Coll Cardiol. 2012 Dec 4;60(22):2263-70</RefSource>
<PMID Version="1">23194937</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Cardiol. 2013 Jan 15;111(2):219-24</RefSource>
<PMID Version="1">23127690</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(2):e57183</RefSource>
<PMID Version="1">23451184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ J. 2013;77(4):864-8</RefSource>
<PMID Version="1">23449371</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(4):e61803</RefSource>
<PMID Version="1">23626730</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Sci (Lond). 2013 Sep;125(6):301-9</RefSource>
<PMID Version="1">23596966</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2013 Oct;59(4):859-71</RefSource>
<PMID Version="1">23751754</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circulation. 2014 Feb 25;129(8):837-47</RefSource>
<PMID Version="1">24345399</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>World J Gastroenterol. 2014 Feb 21;20(7):1724-45</RefSource>
<PMID Version="1">24587651</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Res. 2014 Mar 14;114(6):1004-21</RefSource>
<PMID Version="1">24625726</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMJ Open. 2014;4(3):e004973</RefSource>
<PMID Version="1">24650811</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>World J Gastroenterol. 2014 Jul 14;20(26):8407-15</RefSource>
<PMID Version="1">25024598</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Cardiovasc Electrophysiol. 2014 Jul;25(7):719-24</RefSource>
<PMID Version="1">24602026</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>World J Gastroenterol. 2014 Jul 21;20(27):9026-37</RefSource>
<PMID Version="1">25083076</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Heart. 2014 Oct;100(19):1511-6</RefSource>
<PMID Version="1">24924619</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>World J Gastroenterol. 2014 Sep 28;20(36):12956-80</RefSource>
<PMID Version="1">25278691</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Diabetes Endocrinol. 2014 Nov;2(11):901-10</RefSource>
<PMID Version="1">24731669</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ Cardiovasc Imaging. 2015 Jan;8(1). pii: e001979. doi: 10.1161/CIRCIMAGING.114.001979</RefSource>
<PMID Version="1">25550397</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70</RefSource>
<PMID Version="1">25712077</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dig Liver Dis. 2015 Mar;47(3):181-90</RefSource>
<PMID Version="1">25739820</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ J. 2015;79(3):495-502</RefSource>
<PMID Version="1">25746525</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2015 Apr;62(4):928-33</RefSource>
<PMID Version="1">25445395</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cardiovasc Diabetol. 2015;14:23</RefSource>
<PMID Version="1">25849783</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Expert Rev Gastroenterol Hepatol. 2015 May;9(5):603-27</RefSource>
<PMID Version="1">25694178</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>QJM. 2015 Aug;108(8):617-24</RefSource>
<PMID Version="1">25614616</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Circ J. 2007 Jun;71(6):814-9</RefSource>
<PMID Version="1">17526974</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">PMC4646339</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="ecollection">
<Year>2015</Year>
<Month></Month>
<Day></Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="received">
<Year>2015</Year>
<Month>8</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2015</Year>
<Month>10</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="epublish">
<Year>2015</Year>
<Month>11</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>11</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>11</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>11</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="doi">10.1371/journal.pone.0142937</ArticleId>
<ArticleId IdType="pii">PONE-D-15-36449</ArticleId>
<ArticleId IdType="pubmed">26571029</ArticleId>
<ArticleId IdType="pmc">PMC4646339</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Finlande</li>
</country>
</list>
<tree>
<country name="Finlande">
<noRegion>
<name sortKey="K R J M Ki, Aki J" sort="K R J M Ki, Aki J" uniqKey="K R J M Ki A" first="Aki J" last="K R J M Ki">Aki J. K R J M Ki</name>
</noRegion>
<name sortKey="Huikuri, Heikki" sort="Huikuri, Heikki" uniqKey="Huikuri H" first="Heikki" last="Huikuri">Heikki Huikuri</name>
<name sortKey="Kes Niemi, Y Antero" sort="Kes Niemi, Y Antero" uniqKey="Kes Niemi Y" first="Y Antero" last="Kes Niemi">Y Antero Kes Niemi</name>
<name sortKey="P Tsi, Olli Pekka" sort="P Tsi, Olli Pekka" uniqKey="P Tsi O" first="Olli-Pekka" last="P Tsi">Olli-Pekka P Tsi</name>
<name sortKey="Savolainen, Markku" sort="Savolainen, Markku" uniqKey="Savolainen M" first="Markku" last="Savolainen">Markku Savolainen</name>
<name sortKey="Ukkola, Olavi" sort="Ukkola, Olavi" uniqKey="Ukkola O" first="Olavi" last="Ukkola">Olavi Ukkola</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000078 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000078 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Musique
   |area=    OperaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:26571029
   |texte=   Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:26571029" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a OperaV1 

Wicri

This area was generated with Dilib version V0.6.21.
Data generation: Thu Apr 14 14:59:05 2016. Site generation: Thu Oct 8 06:48:41 2020